VP of SciClone Pharmaceuticals was just granted 50,000 options


Raymond Anthony Low, VP of SciClone Pharmaceuticals, just received 50,000 options from the company. The strike price of the options received was $4.75, and these expire on October 15, 2023. Low now owns at least 50,000 options on the company.

Some additional info was provided as follows:

Granted under the Issuer's 2005 Equity Incentive Plan. 25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To rec eive a free e-mail notification whenever SciClone Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

Current report, items 8.01 and 9.01 - Aug. 28, 2014

   Auto Refresh

Feedback